Literature DB >> 11344123

Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation.

M Menegazzi1, E Tedeschi, D Dussin, A C De Prati, E Cavalieri, S Mariotto, H Suzuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11344123     DOI： 10.1096/fj.00-0519fje

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  31 in total

1.  Role of STAT1 and Oxidative Stress in Gentamicin-Induced Hair Cell Death in Organ of Corti.

Authors:  Peng Jiang; Amrita Ray; Leonard P Rybak; Michael J Brenner
Journal:  Otol Neurotol       Date:  2016-10       Impact factor: 2.311

2.  Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin αvβ3.

Authors:  Jun Ishihara; Terumasa Umemoto; Masayuki Yamato; Yoshiko Shiratsuchi; Satoshi Takaki; Brian G Petrich; Hiromitsu Nakauchi; Koji Eto; Toshio Kitamura; Teruo Okano
Journal:  Int J Hematol       Date:  2014-02-22       Impact factor: 2.490

3.  Elevated levels of STAT1 in Fanconi anemia group A lymphoblasts correlate with the cells' sensitivity to DNA interstrand crosslinking drugs.

Authors:  Inés Prieto-Remón; Dámaso Sánchez-Carrera; Mónica López-Duarte; Carlos Richard; Carlos Pipaón
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

4.  Signaling of short- and long-term regulation of intestinal epithelial type 1 Na+/H+ exchanger by interferon-gamma.

Authors:  Fernando Magro; Sónia Fraga; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

5.  Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut.

Authors:  Carmelo Muià; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Marta Menegazzi; Achille P Caputi; Hisanori Suzuki; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-05       Impact factor: 3.000

6.  Tumor cells upregulate normoxic HIF-1α in response to doxorubicin.

Authors:  Yiting Cao; Joseph M Eble; Ejung Moon; Hong Yuan; Douglas H Weitzel; Chelsea D Landon; Charleen Yu-Chih Nien; Gabi Hanna; Jeremy N Rich; James M Provenzale; Mark W Dewhirst
Journal:  Cancer Res       Date:  2013-08-19       Impact factor: 12.701

Review 7.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

8.  Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoid.

Authors:  Elena Darra; Kazuo Shoji; Sofia Mariotto; Hisanori Suzuki
Journal:  Genes Nutr       Date:  2007-10-11       Impact factor: 5.523

9.  Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation.

Authors:  Fernando Magro; Sónia Fraga; Tomé Ribeiro; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

10.  Effect of epigallocatechin-3-gallate on graft-versus-host disease.

Authors:  Jaebok Choi; Matthew L Cooper; Edward D Ziga; Julie Ritchey; John F DiPersio
Journal:  Cell Transplant       Date:  2014       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.